These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 14049774)

  • 1. [TREATMENT OF GONORRHEA WITH TRIACETYLOLEANDOMYCIN (TAO)].
    PRZYLIPIAK R; CHODYN E; LUKOWICZ M
    Pol Tyg Lek; 1963 Mar; 18():439-40. PubMed ID: 14049774
    [No Abstract]   [Full Text] [Related]  

  • 2. [The treatment of gonorrhea by triacetyloleandomycin].
    THIERS H; RIVOIRE J
    Lyon Med; 1962 Jan; 94():5-12. PubMed ID: 13920666
    [No Abstract]   [Full Text] [Related]  

  • 3. [Therapeutic trial of triacetyloleandomycin (TAO) in infections caused by gram-positive bacteria and Klebsiella].
    KRALJEVIC R; BORGONO JM; VILLALOBOS M; MENDOZA A
    Rev Med Chil; 1960 Aug; 88():644-7. PubMed ID: 13753910
    [No Abstract]   [Full Text] [Related]  

  • 4. Triacetyloleandomycin (TAO)-its value in acne and certain pyogenic skin eruptions. J.
    LOVEMAN AB; HAMMOND K
    J Ky Med Assoc; 1959 Dec; 57():1507-10. PubMed ID: 13853712
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of gangrenous teeth with TAO(triacetyloleandomycin)].
    Strobl I
    Dtsch Zahnarztl Z; 1968 Jul; 23(7):710-3. PubMed ID: 5301888
    [No Abstract]   [Full Text] [Related]  

  • 6. [Studies of the hepatotoxicity of triacetyloleandomycin (TAO) in humans].
    Sasso C; Arpino E
    Minerva Med; 1969 May; 60(35):1689-94. PubMed ID: 5306225
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment of acute male gonorrhoea with triacetyloleandomycin (TAO) (author's transl)].
    Klíma J
    Cesk Dermatol; 1976 Apr; 51(2):113-6. PubMed ID: 776417
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of low-dose troleandomycin on glucocorticoid pharmacokinetics and airway hyperresponsiveness in severely asthmatic children.
    Ball BD; Hill MR; Brenner M; Sanks R; Szefler SJ
    Ann Allergy; 1990 Jul; 65(1):37-45. PubMed ID: 2195921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A new anti-staphylococcal agent of value: triacetyloleandomycin. Results of the treatment of various staphylococcias by triacetyloleandomycin in hospital milieu].
    KOSKAS R; ZIRAH P
    Tunis Med; 1961; 39():615-26. PubMed ID: 14458647
    [No Abstract]   [Full Text] [Related]  

  • 10. The use of triacetyloleandomycin in skin and soft tissue infections: results of a New Zealand general-practitioner multi-centre trial.
    Vaughan GP; Vaughan AM
    N Z Med J; 1977 Oct; 86(598):385-6. PubMed ID: 305017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Severe pneumopathy caused by hemolytic Staphylococcus albus. Its treatment with triacetyloleandomycin].
    VALLA OA; MIEREZ L; ACERBI N
    Dia Med; 1962 Aug; 34():1497-501. PubMed ID: 13995890
    [No Abstract]   [Full Text] [Related]  

  • 12. [RESULTS OBTAINED WITH TRIACETYLOLEANDOMYCIN IN STAPHYLOCOCCIC HYDROSADENITIS].
    MOLINA EB; VIVOT NA
    Prensa Med Argent; 1963 Jun; 50():1476-8. PubMed ID: 14083489
    [No Abstract]   [Full Text] [Related]  

  • 13. [On a case of tibial staphylococcal osteomyelitis treated with triacetyloleandomycin].
    NOVELLO AC; VALOTTA OJ
    Prensa Med Argent; 1962 Aug; 49():1824-6. PubMed ID: 13939116
    [No Abstract]   [Full Text] [Related]  

  • 14. Protection of ethanol-mediated acetaminophen hepatotoxicity by triacetyloleandomycin, a specific inhibitor of CYP3A.
    Kostrubsky VE; Szakacs JG; Jeffery EH; Woods SG; Bement WJ; Wrighton SA; Sinclair PR; Sinclair JF
    Ann Clin Lab Sci; 1997; 27(1):57-62. PubMed ID: 8997458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Morphometric studies in triacetyloleandomycin-induced ultrastructural modifications of rat hepatocyte mitochondria.
    Djaczenko W; Garaci E; Damiani S
    Chemotherapy; 1977; 23(3):167-78. PubMed ID: 300051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic function in acne vulgaris patients treated with triacetyloleandomycin: A preliminary report.
    WEINER AL; COHEN W
    J New Drugs; 1962; 2():307-9. PubMed ID: 13999593
    [No Abstract]   [Full Text] [Related]  

  • 17. TRIACETYLOLEANDOMYCIN IN PURULENT TONSILLITIS AND PERITONSILLAR ABSCESS.
    YOUNG JR
    Eye Ear Nose Throat Mon; 1964 Oct; 43():49-54. PubMed ID: 14217280
    [No Abstract]   [Full Text] [Related]  

  • 18. LIVER FUNCTION STUDIES IN LONG-TERM TRIACETYLOLEANDOMYCIN THERAPY.
    ENGEL MF
    South Med J; 1963 Nov; 56():1279-81. PubMed ID: 14078379
    [No Abstract]   [Full Text] [Related]  

  • 19. [Triacetyloleandomycin in the treatment of acne].
    SMITH H
    Union Med Can; 1963 Mar; 92():332-4. PubMed ID: 13989430
    [No Abstract]   [Full Text] [Related]  

  • 20. Troleandomycin effects on methylprednisolone and methylprednisone interconversion and disposition in the rabbit.
    Ebling WF; Rich SA; Szefler SJ; Jusko WJ
    Eur J Drug Metab Pharmacokinet; 1987; 12(1):50-7. PubMed ID: 3497038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.